![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2017
Graf, S. A.; Strieder, A.; Meierjohann, S.; Heppt, M. V.; Kammerbauer, C. und Berking, C.
(2017):
Inhibition of FGF receptors for effective treatment of BRAF- and BRAF/MEK inhibitor-resistant melanoma cells.
In: Experimental Dermatology, Bd. 26, Nr. 3, E92-E92
Graf, S. A.; Heppt, M. V.; Krebs, S.; Kammerbauer, C.; Hornig, E.; Strieder, A.; Blum, H. und Berking, C.
(2017):
Peripheral myelin protein 2 is a target gene of the transcription factor SOX10 in melanoma and affects tumor cell invasion.
In: Experimental Dermatology, Bd. 26, Nr. 3, E91-E92
2016
Graf, S. A.; Krebs, S.; Blum, H.; Hornig, E.; Kammerbauer, C.; Hamel, A.; Besch, R. und Berking, C.
(2016):
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion.
In: Experimental Dermatology, Bd. 25, Nr. 3, E39-E39
Hamel, A.; Kammerbauer, C.; Graf, S. A. und Berking, C.
(2016):
Targeted combination therapy for BRAF/MEK inhibitor-resistant melanoma cells.
In: Experimental Dermatology, Bd. 25, Nr. 3, E37-E37
Hornig, E.; Heppt, M.; Graf, S. A.; Kammerbauer, C.; Hohenauer, T. und Berking, C.
(2016):
Epigenetic and transcriptional regulation of Brn3a in melanoma.
In: Experimental Dermatology, Bd. 25, Nr. 3, E40-E41